Voyageur Pharmaceuticals (CVE:VM) Trading 47.4% Higher – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) was up 47.4% during mid-day trading on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares changed hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Trading Up 47.4 %

The business has a 50-day simple moving average of C$0.07 and a 200-day simple moving average of C$0.06. The company has a market cap of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.